RE:RE:RE:RE:pan can protocols
Hello Noteable and I hope you are right as I remember Kirk saying that at the cc presentation on the Friday and then on Monday August 14th (3 days later) for the quarterly cc this is a quote from Matt as I have the transcript.I had the transcript for the Friday fireside chat with Cannacord but cannot find that but I do agree that Kirk said at that time that he expected September.
Our plan for this indication is to finalize agreements with the Precision Promise team by the fourth quarter of this year, and we expect to open the investigational treatment of pela a checkpoint inhibitor gemcitabine and nab-paclitaxel in early 2024.
I guess we will all know soon enough and hope that there is enough information given in regards to the agreement to add more excitement to the company with hopefully the announcement of the ci they are going to use or maybe even a partner although that could come at a later date.